Equity Overview
Price & Market Data
Price: $205.0
Daily Change: +$2.49 / 1.21%
Daily Range: $205.0 - $210.4
Market Cap: $14,452,268,032
Daily Volume: 231,759
Performance Metrics
1 Week: -2.11%
1 Month: -14.54%
3 Months: -30.21%
6 Months: -34.09%
1 Year: -16.85%
YTD: -27.73%
Company Details
Employees: 5400
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.